Dokumeds – Inpharmatis cooperation.


Inpharmatis is  a specialised service provider in regulatory and pharmacovigilance.  Dokumeds and Inpharmatis started discussion on opportunities to provide shared services for pharma companies operating in the Eurasian Economic Union (EAEU*) and Ukraine.  In June the two companies signed a cooperation agreement, after sharing their joint capabilities at the DIA Euromeeting in Switzerland in  April. The companies will have a joint booth in CPHI in October (Madrid).

Evolving regulatory framework for EAEU markets requires GMP auditing of manufacturers intending to place their product on the market. Full scope of services starting from regulatory consultancy, organizing and supporting manufacturing site GMP inspection, gap analysis of product dossier, clinical trial protocol development and obtaining of marketing authorization are able to be carried out by joint teams of Dokumeds-Inpharmatis. From the other side, as more pharma companies from EAEU and Ukraine are targeting the market of EU countries, Dokumeds-Inpharmatis joint collaboration model ensures implementation of smooth development program targeting EU marketing authorization with a tailored approach.

*The Member-States of the Eurasian Economic Union are the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic and the Russian Federation.

 


Meet me at this event

 
1 Start 2 Complete